Hepatic Arterial Chemoembolization With Arsenic Trioxide Eluting CalliSpheres Microspheres Versus Lipiodol Emulsion: Pharmacokinetics And Intratumoral Concentration In A Rabbit Liver Tumor Model

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Jemal A, Ward EM, Johnson CJ, et al. Annual report to the nation on the status of cancer, 1975–2014, featuring survival. J Natl Cancer Inst. 2017;109(9):djx030.
   PubMedGoogle Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30. doi:10.3322/caac.2144229313949
   PubMed Web of Science ®Google Scholar
• Antman KH. Introduction: the history of arsenic trioxide in cancer therapy. Oncologist. 2001;6(suppl 2):1–2. doi:10.1634/theoncologist.6-suppl_2-1
   PubMed Web of Science ®Google Scholar
• Leung LL, Lam S-K, Li -Y-Y, Ho JC-M. Tumour growth-suppressive effect of arsenic trioxide in squamous cell lung carcinoma. Oncol Lett. 2017;14(3):3748–3754. doi:10.3892/ol.2017.664628927142
   PubMed Web of Science ®Google Scholar
• Stevens JJ, Graham B, Dugo E, et al. Arsenic trioxide induces apoptosis via specific signaling pathways in HT-29 colon cancer cells. J Cancer Sci Ther. 2017;9(1):298–306. doi:10.4172/1948-595628966729
   PubMedGoogle Scholar
• Shi Y, Cao T, Huang H, et al. Arsenic trioxide inhibits cell growth and motility via up-regulation of let-7a in breast cancer cells. Cell Cycle. 2017;16(24):2396–2403. doi:10.1080/15384101.2017.138769928980872
   PubMed Web of Science ®Google Scholar
• Zhang X, Jia S, Yang S, et al. Arsenic trioxide induces G2/M arrest in hepatocellular carcinoma cells by increasing the tumor suppressor PTEN expression. J Cell Biochem. 2012;113(11):3528–3535. doi:10.1002/jcb.v113.1122730174
   PubMed Web of Science ®Google Scholar
• Alarifi S, Ali D, Alkahtani S, Siddiqui MA, Ali BA. Arsenic trioxide-mediated oxidative stress and genotoxicity in human hepatocellular carcinoma cells. Onco Targets Ther. 2013;6:75–84. doi:10.2147/OTT.S3822723404534
   PubMed Web of Science ®Google Scholar
• Tan B, Huang J-F, Wei Q, Zhang H, Ni R-Z. Anti-hepatoma effect of arsenic trioxide on experimental liver cancer induced by 2-acetamidofluorene in rats. World J Gastroenterol. 2005;11(38):5938–5943. doi:10.3748/wjg.v11.i38.593816273603
   PubMed Web of Science ®Google Scholar
• Lin CC, Hsu C, Hsu CH, et al. Arsenic trioxide in patients with hepatocellular carcinoma: a phase II trial. Invest New Drugs. 2007;25(1):77–84. doi:10.1007/s10637-006-9004-916937079
   PubMed Web of Science ®Google Scholar
• Barbey JT. Cardiac toxicity of arsenic trioxide. Blood. 2001;98(5):1632. doi:10.1182/blood.V98.5.163211547771
   PubMedGoogle Scholar
• GA R, El-Gareib AW. Toxic effects of gestational arsenic trioxide on the neuroendocrine axis of developing rats. Food Chem Toxicol. 2018.
   Google Scholar
• Swindell EP, Hankins PL, Chen H, Miodragovic DU, O’Halloran TV. Anticancer activity of small-molecule and nanoparticulate arsenic(III) complexes. Inorg Chem. 2013;52(21):12292–12304. doi:10.1021/ic401211u24147771
   PubMed Web of Science ®Google Scholar
• Song X, You J, Shao H, Yan C. Effects of surface modification of As2O3-loaded PLGA nanoparticles on its anti-liver cancer ability: an in vitro and in vivo study. Colloids Surf B Biointerfaces. 2018;169:289–297. doi:10.1016/j.colsurfb.2018.05.02429793091
   PubMed Web of Science ®Google Scholar
• Gallkowski U, Low A, Hirner A. Regional chemotherapy and transcatheter arterial chemoembolization. Digestion. 1998;59(suppl 2):83–85. doi:10.1159/0000514339718432
   PubMedGoogle Scholar
• Liapi E, Georgiades CC, Hong K, Geschwind J-FH. Transcatheter arterial chemoembolization: current technique and future promise. Tech Vasc Interventional Radiol. 2007;10(1):2–11. doi:10.1053/j.tvir.2007.08.008
   PubMedGoogle Scholar
• Kim HJ, Shin JH, Kim TH, et al. Efficacy of transarterial embolization with arsenic trioxide oil emulsion in a rabbit VX2 liver tumor model. J Vasc Interv Radiol. 2009;20(10):1365–1370. doi:10.1016/j.jvir.2009.07.00519713126
   PubMed Web of Science ®Google Scholar
• Li H, Gong J, Jiang X, Shao H. Arsenic trioxide treatment of rabbit liver VX-2 carcinoma via hepatic arterial cannulation-induced apoptosis and decreased levels of survivin in the tumor tissue. Croat Med J. 2013;54(1):12–16. doi:10.3325/cmj.2013.54.1223444241
   PubMed Web of Science ®Google Scholar
• Choi JW, Cho HJ, Park JH, et al. Comparison of drug release and pharmacokinetics after transarterial chemoembolization using diverse lipiodol emulsions and drug-eluting beads. PLoS One. 2014;9(12):e115898. doi:10.1371/journal.pone.011589825551760
   PubMed Web of Science ®Google Scholar
• Gupta S, Wright KC, Ensor J, et al. Hepatic arterial embolization with doxorubicin-loaded superabsorbent polymer microspheres in a rabbit liver tumor model. Cardiovasc Intervent Radiol. 2011;34(5):1021–1030. doi:10.1007/s00270-011-0154-621479746
   PubMed Web of Science ®Google Scholar
• Hong K, Khwaja A, Liapi E, et al. New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer. Clin Cancer Res. 2006;12(8):2563–2567. doi:10.1158/1078-0432.CCR-05-222516638866
   PubMed Web of Science ®Google Scholar
• Zhang S, Huang C, Li Z, et al. Comparison of pharmacokinetics and drug release in tissues after transarterial chemoembolization with doxorubicin using diverse lipiodol emulsions and CalliSpheres beads in rabbit livers. Drug Deliv. 2017;24(1):1011–1017. doi:10.1080/10717544.2017.134433628660787
   PubMed Web of Science ®Google Scholar
• Parvinian A, Casadaban LC, Hauck ZZ, van Breemen RB, Gaba RC. Pharmacokinetic study of conventional sorafenib chemoembolization in a rabbit VX2 liver tumor model. Diagn Interv Radiol. 2015;21(3):235–240. doi:10.5152/dir25835078
   PubMed Web of Science ®Google Scholar
• Hu HT, Yao QJ, Meng YL, et al. Arsenic trioxide intravenous infusion combined with transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with pulmonary metastasis: long-term outcome analysis. J Gastroenterol Hepatol. 2017;32(2):295–300. doi:10.1111/jgh.2017.32.issue-227517972
   PubMed Web of Science ®Google Scholar
• Li SW, He Y, Zhao HJ, et al. Assessment of 28 trace elements and 17 amino acid levels in muscular tissues of broiler chicken (Gallus gallus) suffering from arsenic trioxide. Ecotoxicol Environ Saf. 2017;144:430–437. doi:10.1016/j.ecoenv.2017.06.06128666216
   PubMed Web of Science ®Google Scholar
• Jiang L, Wang L, Chen L, et al. As(2)O(3) induces apoptosis in human hepatocellular carcinoma HepG2 cells through a ROS-mediated mitochondrial pathway and activation of caspases. Int J Clin Exp Med. 2015;8(2):2190–2196.25932150
   PubMed Web of Science ®Google Scholar
• Cui X, Wakai T, Shirai Y, et al. Arsenic trioxide inhibits DNA methyltransferase and restores methylation-silenced genes in human liver cancer cells. Hum Pathol. 2006;37(3):298–311. doi:10.1016/j.humpath.2005.10.01316613325
   PubMed Web of Science ®Google Scholar
• Shooshtary S, Behtash S, Nafisi S. Arsenic trioxide binding to serum proteins. J Photochem Photobiol B. 2015;148:31–36. doi:10.1016/j.jphotobiol.2015.03.00125863441
   PubMed Web of Science ®Google Scholar
• Song MJ, Park CH, Kim JD, et al. Drug-eluting bead loaded with doxorubicin versus conventional Lipiodol-based transarterial chemoembolization in the treatment of hepatocellular carcinoma: a case-control study of Asian patients. Eur J Gastroenterol Hepatol. 2011;23(6):521–527. doi:10.1097/MEG.0b013e328346d50521537127
   PubMed Web of Science ®Google Scholar
• Seki A, Hori S. Switching the loaded agent from epirubicin to cisplatin: salvage transcatheter arterial chemoembolization with drug-eluting microspheres for unresectable hepatocellular carcinoma. Cardiovasc Intervent Radiol. 2012;35(3):555–562. doi:10.1007/s00270-011-0176-021562932
   PubMed Web of Science ®Google Scholar
• Lee KH, Liapi EA, Cornell C, et al. Doxorubicin-loaded QuadraSphere microspheres: plasma pharmacokinetics and intratumoral drug concentration in an animal model of liver cancer. Cardiovasc Intervent Radiol. 2010;33(3):576–582. doi:10.1007/s00270-010-9794-120087738
   PubMed Web of Science ®Google Scholar